Table I Index
Table of Contents
Table I - 48 Madison Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 656 | 384.0 | 336 | 466.3 | 320 | 333.9 |
Oral cavity and pharynx | 19 | 11.5** | 14 | 19.2** | 5 | 4.8** |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 116 | 64.6 | 56 | 76.2 | 60 | 56.6 |
Esophagus | 10 | 5.5** | 5 | 6.6** | 5 | 4.4** |
Stomach | 13 | 7.1** | * | # | 10 | 9.4** |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 61 | 33.8 | 34 | 46.3 | 27 | 25.6 |
Rectum and rectosigmoid | 7 | 4.2** | * | # | 5 | 5.9** |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | 13 | 7.4** | 6 | 8.5** | 7 | 5.9** |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 127 | 77.0 | 76 | 108.6 | 51 | 53.3 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 9 | 6.0** | 8 | 11.8** | * | # |
Lung and bronchus | 117 | 70.4 | 67 | 95.4 | 50 | 52.5 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | 5 | 3.0** | * | # | * | # |
Skin (excluding basal and squamous) | 18 | 12.0** | 6 | 9.4** | 12 | 13.9** |
Melanoma of the skin | 17 | 11.4** | 5 | 8.3** | 12 | 13.9** |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 78 | 46.9 | * | # | 77 | 84.7 |
Female genital system | 45 | 27.3 | -- | -- | 45 | 50.7 |
Cervix uteri | 6 | 3.8** | -- | -- | 6 | 7.3** |
Corpus uteri | 23 | 13.7 | -- | -- | 23 | 25.2 |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 12 | 7.1** | -- | -- | 12 | 13.2** |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 101 | 57.1 | 101 | 138.9 | -- | -- |
Prostate gland | 97 | 54.5 | 97 | 133.7 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 49 | 28.9 | 30 | 43.3 | 19 | 19.1** |
Urinary bladder | 34 | 19.3 | 24 | 34.6 | 10 | 9.0** |
Kidney and renal pelvis | 14 | 9.1** | 6 | 8.7** | 8 | 9.3** |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | 13 | 7.9** | 6 | 7.6** | 7 | 8.3** |
Brain | 13 | 7.9** | 6 | 7.6** | 7 | 8.3** |
Other nervous system | * | # | * | # | * | # |
Endocrine system | 5 | 3.3** | * | # | * | # |
Thyroid gland | 5 | 3.3** | * | # | * | # |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 35 | 20.2 | 16 | 21.3** | 19 | 18.6** |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | 34 | 19.6 | 15 | 20.2** | 19 | 18.6** |
Multiple myeloma | 9 | 4.4** | * | # | 5 | 3.8** |
Leukemia | 17 | 8.4** | 11 | 14.1** | 6 | 4.4** |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | 6 | 2.6** | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | 7 | 3.8** | 6 | 8.0** | * | # |
Other, ill-defined and unknown sites | 19 | 11.6** | 11 | 15.2** | 8 | 8.9** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |